Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diurnal variation in amitriptyline PK/PD in healthy Korean and Japanese adults
jRCTs021190009Completed
- Sponsor
- Korea National Enterprise for Clinical Trials
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label, single-arm trial of amitriptyline in major depressive disorder (MDD), nocturnal enuresis (NE) and Peripheral neuropathy, sponsored by Korea National Enterprise for Clinical Trials. Primary endpoint: Effect of diurnal variation on amitriptyline pharmacokinetics and pharmacodynamics. Started Oct 2019; status: completed.
02
Drugs
amitriptyline
03
Conditions
major depressive disorder (MDD)nocturnal enuresis (NE)Peripheral neuropathy
Beyond the preview
Go deeper on jRCTs021190009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021190009.